Duchenne's Muscular Dystrophy (DMD) Completed Phase 1 / 2 Trials for Eteplirsen (DB06014)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00159250Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular DystrophyTreatment
NCT00844597Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) PatientsTreatment